Staar SurgicalStaar Surgical today announced the first implants of the Evo Visian implantable Collamer lens in the U.S.

Lake Forest, California-based Staar Surgical designed the Evo biocompatible implantable lens for the correction of myopia and myopia with astigmatism. The first implant was performed in a woman with myopia and astigmatism in her thirties who previously used monthly disposable contact lenses and glasses. She received toric Evo ICL lenses for visual freedom and to eliminate the need for contact lenses and glasses.

The bilateral Evo implantation procedure was completed in approximately 7-8 minutes for each eye.

“We are thrilled to begin commercialization of our Evo lenses in the U.S. and announce milestone first implants just days after product approval,” Caren Mason, president and CEO, said in a news release. “The U.S. is a very important market for Staar as it represents over 20% of global refractive procedures. U.S. surgeon enthusiasm is at an all-time high ahead of the ASCRS Annual Meeting later this month. We look forward to a strong and exciting showcasing of Evo ICL presentations and events at ASCRS and anticipate certifying hundreds of U.S. surgeons on Evo ICL implantation during the second quarter of 2022.”